These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 21599672)

  • 1. Adjudicating bleeding events in a platelet dose study: impact on outcome results and challenges.
    Heddle NM; Wu C; Vassallo R; Carey P; Arnold D; Lozano M; Pavenski K; Sweeney J; Stanworth S; Liu Y; Traore A; Barty R; Tinmouth A;
    Transfusion; 2011 Nov; 51(11):2304-10. PubMed ID: 21599672
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Measuring clinical bleeding using a standardized daily report form and a computer algorithm for adjudication of WHO bleeding grades.
    Middelburg RA; Ypma PF; van der Meer PF; van Wordragen-Vlaswinkel RJ; Eissen O; Kerkhoffs JL
    Vox Sang; 2013 Aug; 105(2):144-9. PubMed ID: 23517250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adjudication of bleeding outcomes in an international thromboprophylaxis trial in critical illness.
    Arnold DM; Lauzier F; Rabbat C; Zytaruk N; Barlow Cash B; Clarke F; Heels-Ansdell D; Guyatt G; Walter SD; Davies A; Cook DJ;
    Thromb Res; 2013 Mar; 131(3):204-9. PubMed ID: 23317632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Background, rationale, and design of a clinical trial to assess the effects of platelet dose on bleeding risk in thrombocytopenic patients.
    Slichter SJ
    J Clin Apher; 2006 Apr; 21(1):78-84. PubMed ID: 16619231
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The challenges of measuring bleeding outcomes in clinical trials of platelet transfusions.
    Estcourt LJ; Heddle N; Kaufman R; McCullough J; Murphy MF; Slichter S; Wood EM; Stanworth SJ;
    Transfusion; 2013 Jul; 53(7):1531-43. PubMed ID: 23305609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute bleeding complications in patients after hematopoietic stem cell transplantation with prophylactic platelet transfusion triggers of 10 x 10(9) and 20 x 10(9) per L.
    Nevo S; Fuller AK; Hartley E; Borinsky ME; Vogelsang GB
    Transfusion; 2007 May; 47(5):801-12. PubMed ID: 17465944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The threshold for prophylactic platelet transfusions in adults with acute myeloid leukemia. Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto.
    Rebulla P; Finazzi G; Marangoni F; Avvisati G; Gugliotta L; Tognoni G; Barbui T; Mandelli F; Sirchia G
    N Engl J Med; 1997 Dec; 337(26):1870-5. PubMed ID: 9407153
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methods for the analysis of bleeding outcomes in randomized trials of PLT transfusion triggers.
    Cook RJ; Heddle NM; Rebulla P; Sigouin CS; Webert KE;
    Transfusion; 2004 Aug; 44(8):1135-42. PubMed ID: 15265116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bleeding and surgery in children with Glanzmann thrombasthenia with and without the use of recombinant factor VII a.
    Hennewig U; Laws HJ; Eisert S; Göbel U
    Klin Padiatr; 2005; 217(6):365-70. PubMed ID: 16307424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The clinical impact of platelet refractoriness: correlation with bleeding and survival.
    Kerkhoffs JL; Eikenboom JC; van de Watering LM; van Wordragen-Vlaswinkel RJ; Wijermans PW; Brand A
    Transfusion; 2008 Sep; 48(9):1959-65. PubMed ID: 18564396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low-dose prophylactic platelet transfusions in recipients of an autologous peripheral blood progenitor cell transplant and patients with acute leukemia: a randomized controlled trial with a sequential Bayesian design.
    Tinmouth A; Tannock IF; Crump M; Tomlinson G; Brandwein J; Minden M; Sutton D
    Transfusion; 2004 Dec; 44(12):1711-9. PubMed ID: 15584985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcome assessment for clinical trials: how many adjudicators do we need? Canadian Lung Oncology Group.
    Walter SD; Cook DJ; Guyatt GH; King D; Troyan S
    Control Clin Trials; 1997 Feb; 18(1):27-42. PubMed ID: 9055050
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcomes assessment in the SPRINT multicenter tibial fracture trial: Adjudication committee size has trivial effect on trial results.
    ; Simunovic N; Walter S; Devereaux PJ; Sprague S; Guyatt GH; Schemitsch E; Tornetta P; Sanders D; Swiontkowski M; Bhandari M
    J Clin Epidemiol; 2011 Sep; 64(9):1023-33. PubMed ID: 21439784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical safety of platelets photochemically treated with amotosalen HCl and ultraviolet A light for pathogen inactivation: the SPRINT trial.
    Snyder E; McCullough J; Slichter SJ; Strauss RG; Lopez-Plaza I; Lin JS; Corash L; Conlan MG;
    Transfusion; 2005 Dec; 45(12):1864-75. PubMed ID: 16371039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimal preprocedural platelet transfusion threshold for central venous catheter insertions in patients with thrombocytopenia.
    Zeidler K; Arn K; Senn O; Schanz U; Stussi G
    Transfusion; 2011 Nov; 51(11):2269-76. PubMed ID: 21517892
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platelet transfusions in infants with necrotizing enterocolitis do not lower mortality but may increase morbidity.
    Kenton AB; Hegemier S; Smith EO; O'Donovan DJ; Brandt ML; Cass DL; Helmrath MA; Washburn K; Weihe EK; Fernandes CJ
    J Perinatol; 2005 Mar; 25(3):173-7. PubMed ID: 15578029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bleeding risk and platelet transfusion refractoriness in patients with acute myelogenous leukemia who undergo autologous stem cell transplantation.
    Toor AA; Choo SY; Little JA
    Bone Marrow Transplant; 2000 Aug; 26(3):315-20. PubMed ID: 10967572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet function testing to assess effectiveness of platelet transfusion therapy.
    Salama ME; Raman S; Drew MJ; Abdel-Raheem M; Mahmood MN
    Transfus Apher Sci; 2004 Apr; 30(2):93-100. PubMed ID: 15062745
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platelet dose consistency and its effect on the number of platelet transfusions for support of thrombocytopenia: an analysis of the SPRINT trial of platelets photochemically treated with amotosalen HCl and ultraviolet A light.
    Murphy S; Snyder E; Cable R; Slichter SJ; Strauss RG; McCullough J; Lin JS; Corash L; Conlan MG;
    Transfusion; 2006 Jan; 46(1):24-33. PubMed ID: 16398727
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A therapeutic platelet transfusion strategy is safe and feasible in patients after autologous peripheral blood stem cell transplantation.
    Wandt H; Schaefer-Eckart K; Frank M; Birkmann J; Wilhelm M
    Bone Marrow Transplant; 2006 Feb; 37(4):387-92. PubMed ID: 16400342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.